ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
COVID vaccines

Japan's Shionogi booster delivers similar results to Pfizer: study

Deliveries of COVID vaccine to start as early as May after trial success

A local resident receives a COVID-19 booster shot at a Tokyo mass vaccination center.    © Reuters

OSAKA -- Japanese drugmaker Shionogi's COVID-19 vaccine candidate was found to be as effective as Pfizer shots as a booster in a late-stage clinical trial, the company announced Friday.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more